Indivior PLC (NASDAQ:INDV) Declares Special Dividend of $8.13

Indivior PLC (NASDAQ:INDV) announced a special dividend on Thursday, September 17th. Investors of record on Friday, October 30th will be given a dividend of 8.13 per share on Friday, November 6th. The ex-dividend date is Friday, October 30th.

Indivior Stock Up 3.9%

NASDAQ:INDV traded up $1.34 during trading hours on Thursday, reaching $35.69. 1,680,788 shares of the stock were exchanged, compared to its average volume of 2,180,127. Indivior has a twelve month low of $22.22 and a twelve month high of $42.81. The business has a 50-day moving average of $37.81 and a two-hundred day moving average of $36.08. The company has a market capitalization of $4.21 billion, a price-to-earnings ratio of 12.79 and a beta of 0.82.

Indivior (NASDAQ:INDV) last issued its quarterly earnings data on Tuesday, June 30th. The company reported $5.75 earnings per share for the quarter. The business had revenue of $343.00 million during the quarter. Indivior had a negative return on equity of 283.11% and a net margin of 26.65%. On average, research analysts forecast that Indivior will post 3.66 EPS for the current fiscal year.

About Indivior

Indivior plc is a specialty pharmaceutical company focused on developing and commercializing medicines for addiction and serious mental health disorders. Its portfolio is primarily centered on treatments for opioid use disorder, with an emphasis on products designed to support recovery, reduce illicit opioid use and address the risk of overdose.

The company’s key products include SUBOXONE sublingual film, a buprenorphine-and-naloxone treatment for opioid use disorder; SUBLOCADE, a long-acting injectable form of buprenorphine; and OPVEE, a nalmefene nasal spray intended for the emergency treatment of opioid overdose.